NASDAQ
Calliditas Therapeutics AB (publ) (CALT) has a fcf yield of -6.43% as of Tuesday, August 4, 2026. This represents a 13.02% decrease compared to its 12-month average of -5.69%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.